nitrates has been researched along with Left Ventricular Hypertrophy in 14 studies
Nitrates: Inorganic or organic salts and esters of nitric acid. These compounds contain the NO3- radical.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Nitrates are effective for the therapy of acute coronary syndromes, including acute myocardial infarction." | 8.79 | Effect of nitrates on myocardial remodeling after acute myocardial infarction. ( Jugdutt, BI, 1996) |
| "The lipid-lowering agent probucol may be efficacious, through its antioxidant properties, to limit and reverse the vascular endothelial dysfunction associated with left ventricular hypertrophy (LVH)." | 7.73 | Role of probucol on endothelial dysfunction of epicardial coronary arteries associated with left ventricular hypertrophy. ( Aubin, MC; Carrier, M; Perrault, LP; Shi, YF; Tardif, JC, 2006) |
| " NO bioavailability was assessed using cyclic guanosine monophosphate quantification." | 5.37 | Atorvastatin worsens left ventricular diastolic dysfunction and endothelial dysfunction of epicardial coronary arteries in normocholesterolemic porcine with left ventricular hypertrophy. ( Aubin, MC; Carrier, M; Forcillo, J; Maltais, S; Perrault, LP; Shi, YF; Tardif, JC, 2011) |
| "Nitrates are effective for the therapy of acute coronary syndromes, including acute myocardial infarction." | 4.79 | Effect of nitrates on myocardial remodeling after acute myocardial infarction. ( Jugdutt, BI, 1996) |
| "The lipid-lowering agent probucol may be efficacious, through its antioxidant properties, to limit and reverse the vascular endothelial dysfunction associated with left ventricular hypertrophy (LVH)." | 3.73 | Role of probucol on endothelial dysfunction of epicardial coronary arteries associated with left ventricular hypertrophy. ( Aubin, MC; Carrier, M; Perrault, LP; Shi, YF; Tardif, JC, 2006) |
| " Besides these proteases, several investigations have demonstrated that reduced endogenous NO bioavailability is a central pathological event in hypertension." | 2.72 | Nitrate and nitrite-based therapy to attenuate cardiovascular remodelling in arterial hypertension. ( Batista, RIM; Guimaraes, DA; Tanus-Santos, JE, 2021) |
| " NO bioavailability was assessed using cyclic guanosine monophosphate quantification." | 1.37 | Atorvastatin worsens left ventricular diastolic dysfunction and endothelial dysfunction of epicardial coronary arteries in normocholesterolemic porcine with left ventricular hypertrophy. ( Aubin, MC; Carrier, M; Forcillo, J; Maltais, S; Perrault, LP; Shi, YF; Tardif, JC, 2011) |
| " Vascular reactivity was assessed in isolated hypertrophied hearts (55+/-3 days after aortic banding or sham operation) by constructing dose-response curves to acetylcholine (ACh), sodium nitroprusside (SNP) and adenosine." | 1.31 | Endogenous and exogenous coronary vasodilatation are attenuated in cardiac hypertrophy: a morphological defect? ( Bovill, E; Flores, NA; Kingsbury, MP; Sheridan, DJ; Turner, MA, 2000) |
| "Liver cirrhosis is associated with enlarged right cardiac chambers." | 1.31 | Modification of cardiac function in cirrhotic patients with and without ascites. ( De Castro, S; Fiore, P; Funaro, S; Lionetti, R; Masini, A; Merli, M; Pulcinelli, G; Riggio, O; Valeriano, V, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (21.43) | 18.2507 |
| 2000's | 5 (35.71) | 29.6817 |
| 2010's | 5 (35.71) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Guimaraes, DA | 1 |
| Batista, RIM | 1 |
| Tanus-Santos, JE | 1 |
| Kamezaki, F | 1 |
| Tsutsui, M | 1 |
| Takahashi, M | 1 |
| Sonoda, S | 1 |
| Kubo, T | 1 |
| Fujino, Y | 1 |
| Adachi, T | 1 |
| Abe, H | 1 |
| Takeuchi, M | 1 |
| Mayumi, T | 1 |
| Otsuji, Y | 1 |
| Bunbupha, S | 1 |
| Prachaney, P | 1 |
| Kukongviriyapan, U | 1 |
| Kukongviriyapan, V | 1 |
| Welbat, JU | 1 |
| Pakdeechote, P | 1 |
| Akcaboy, M | 1 |
| Kula, S | 1 |
| Göktas, T | 1 |
| Nazlıel, B | 1 |
| Terlemez, S | 1 |
| Celik, N | 1 |
| Celik, B | 1 |
| Buyan, N | 1 |
| Sun, Y | 1 |
| Carretero, OA | 1 |
| Xu, J | 1 |
| Rhaleb, NE | 1 |
| Yang, JJ | 1 |
| Pagano, PJ | 1 |
| Yang, XP | 1 |
| Singh, K | 1 |
| Singh, T | 1 |
| Sharma, PL | 1 |
| Forcillo, J | 1 |
| Maltais, S | 1 |
| Aubin, MC | 2 |
| Shi, YF | 2 |
| Carrier, M | 2 |
| Tardif, JC | 2 |
| Perrault, LP | 2 |
| Tiyyagura, SR | 1 |
| Pinney, SP | 1 |
| McDonald, KM | 1 |
| Cohn, JN | 1 |
| Jugdutt, BI | 1 |
| Popović, AD | 1 |
| Kingsbury, MP | 1 |
| Turner, MA | 1 |
| Flores, NA | 1 |
| Bovill, E | 1 |
| Sheridan, DJ | 1 |
| Valeriano, V | 1 |
| Funaro, S | 1 |
| Lionetti, R | 1 |
| Riggio, O | 1 |
| Pulcinelli, G | 1 |
| Fiore, P | 1 |
| Masini, A | 1 |
| De Castro, S | 1 |
| Merli, M | 1 |
4 reviews available for nitrates and Left Ventricular Hypertrophy
| Article | Year |
|---|---|
Nitrate and nitrite-based therapy to attenuate cardiovascular remodelling in arterial hypertension.
Topics: Animals; Antihypertensive Agents; Arteries; Heart; Humans; Hypertension; Hypertrophy, Left Ventricul | 2021 |
Left ventricular remodeling after myocardial infarction: past, present, and future.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Humans; Hypertrop | 2006 |
Effect of nitrates on myocardial remodeling after acute myocardial infarction.
Topics: Animals; Humans; Hypertrophy, Left Ventricular; Myocardial Infarction; Nitrates | 1996 |
Impact of therapy on left ventricular remodeling after myocardial infarction: an echocardiographic perspective.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Echocardiography; Humans; Hyp | 1997 |
10 other studies available for nitrates and Left Ventricular Hypertrophy
| Article | Year |
|---|---|
Plasma levels of nitric oxide metabolites are markedly reduced in normotensive men with electrocardiographically determined left ventricular hypertrophy.
Topics: Adult; Biomarkers; Blood Pressure; Dinoprost; Electrocardiography; Humans; Hypertrophy, Left Ventric | 2014 |
Asiatic acid alleviates cardiovascular remodelling in rats with L-NAME-induced hypertension.
Topics: Animals; Antihypertensive Agents; Aorta; Biomarkers; Blood Pressure; Collagen; Disease Models, Anima | 2015 |
Effect of plasma NOx values on cardiac function in obese hypertensive and normotensive pediatric patients.
Topics: Adolescent; Biomarkers; Blood Pressure Monitoring, Ambulatory; Case-Control Studies; Echocardiograph | 2016 |
Deletion of inducible nitric oxide synthase provides cardioprotection in mice with 2-kidney, 1-clip hypertension.
Topics: Animals; Blood Pressure; Disease Models, Animal; Fibrosis; Gene Deletion; Hypertension, Renovascular | 2009 |
Beneficial effects of angiotensin (1-7) in diabetic rats with cardiomyopathy.
Topics: Angiotensin I; Angiotensin II; Animals; Blood Glucose; Collagen; Diabetes Mellitus, Experimental; Di | 2011 |
Atorvastatin worsens left ventricular diastolic dysfunction and endothelial dysfunction of epicardial coronary arteries in normocholesterolemic porcine with left ventricular hypertrophy.
Topics: Angiotensin II; Animals; Aorta; Atorvastatin; Coronary Vessels; Cyclic GMP; Dose-Response Relationsh | 2011 |
Role of probucol on endothelial dysfunction of epicardial coronary arteries associated with left ventricular hypertrophy.
Topics: Angiotensin II; Animals; Antioxidants; Bradykinin; Coronary Vessels; Cyclic GMP; Endothelium, Vascul | 2006 |
Left ventricular mass and volume after myocardial infarction.
Topics: Adrenergic beta-Antagonists; Humans; Hypertrophy, Left Ventricular; Myocardial Infarction; Nitrates; | 1993 |
Endogenous and exogenous coronary vasodilatation are attenuated in cardiac hypertrophy: a morphological defect?
Topics: Animals; Coronary Circulation; Coronary Vessels; Guinea Pigs; Hyperemia; Hypertrophy, Left Ventricul | 2000 |
Modification of cardiac function in cirrhotic patients with and without ascites.
Topics: Ascites; Cardiomyopathies; Case-Control Studies; Echocardiography; Echocardiography, Doppler, Color; | 2000 |